Side-by-side comparison of AI visibility scores, market position, and capabilities
India no-code options backtesting and live execution platform serving 13K+ traders at $6.9M revenue; $750K YC-backed in world's largest options market competing with Sensibull and Streak for retail algo trading.
AlgoTest is a Bengaluru-based algorithmic options trading platform providing no-code backtesting and live execution tools for retail traders in India's rapidly growing derivatives market — the world's largest by number of contracts traded. Founded in 2022 and backed by Y Combinator with $750,000 raised, AlgoTest generated $6.9 million in revenue in 2024 serving 13,000+ active traders who have executed 12.5 million+ live trades and run 20 million+ backtests on the platform.
Karachi Pakistan earned wage access platform at $64.1M total ($17M Speedinvest/FJ Labs Series A Apr 2022) serving Pakistani employees and SMEs through United Bank Limited and Bank Alfalah; cash flow positive competing with Wagestream for South Asia EWA.
Abhi is a Karachi, Pakistan-based financial wellness and earned wage access platform — backed with $64.1 million in total funding including a $17 million Series A in April 2022 led by Speedinvest with Global Ventures, VentureSouq, VEF (Vostok Emerging Finance), Sturgeon Capital, Rallycap, and FJ Labs, following a pre-Series A in November 2021 led by Global Ventures and a $2 million seed in 2021 from Vostok Emerging Finance — providing Pakistani employees with on-demand access to accrued salary before payday (earned wage access), expanding into B2B business financing services for SMEs, and partnering with United Bank Limited and Bank Alfalah for distribution across hundreds of corporate clients. Founded in 2019 and achieving cash flow positive operations, Abhi serves the Pakistani workforce with financial tools addressing the liquidity gap between salary payment dates that pushes employees toward informal high-cost borrowing.
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.